CSL - Equity Capital And Reserves

Stock Price
139.19
Daily Change
-1.04 -0.74%
Monthly
-2.38%
Yearly
-40.28%
Q2 Forecast
135.92

CSL reported $18.66B in Equity Capital and Reserves for its fiscal semester ending in December of 2025.





Equity Capital And Reserves Change Date
Alterity Therapeutics Limited AUD 36.21M 18.58M Dec/2025
Arca Biopharma USD 469M 17.79M Dec/2025
aTyr Pharma USD -24.12M 104.35M Dec/2025
Bio Path USD -8M 846K Sep/2025
Brainstorm Cell Therapeutics USD -9.98M 2.29M Dec/2025
Cara Therapeutics USD 27.87M 5.06M Sep/2025
CSL USD 18.66B 2.75B Dec/2025
Curis USD 5.46M 19.45M Dec/2025
Esperion Therapeutics USD -301.96M 149.4M Dec/2025
Immunic USD 10.5M 23.41M Sep/2025
Infinity Pharmaceuticals USD -37.41M 9.08M Jun/2023
Minerva Neurosciences USD -140.75M 106.17M Dec/2025
Sangamo BioSciences USD 19.6M 14.7M Jun/2025
TherapeuticsMD USD 27.67M 990K Jun/2024